 |
FDA Approval Activities for this Drug
Neutrexin (trimetrexate glucuronate) Injection, 25 mg, 200 mg, MedImmune Oncology, NDA 20-326/S-011, S-013 | Neutrexin (trimetrexate glucuronate for injection), MedImmune Oncology, Labeling Revision
View updates.
|